| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Medical Officer | Common Stock | 10,121 | $32,185 | $3.18 | 23 May 2023 | Direct |
| RELMADA THERAPEUTICS, INC. | Chief Medical Officer | Stock Option (right to buy) | 400,000 | 06 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS, INC. | 23 May 2023 | 1 | +$31,800 | 4 | Chief Medical Officer | 24 May 2023, 09:00 |
| RLMD | RELMADA THERAPEUTICS, INC. | 06 Jan 2023 | 1 | $0 | 4 | Chief Medical Officer | 13 Jan 2023, 16:54 |
| RLMD | RELMADA THERAPEUTICS, INC. | 06 Jan 2023 | 0 | $0 | 3 | Chief Medical Officer | 13 Jan 2023, 16:54 |